Zydus Lifesciences Limited(IN:ZYDUSLIFE)
₹1,205.50+15.40 (+1.29%)
IN:ZYDUSLIFE
Zydus Lifesciences Limited financials statements
₹1,205.50
At close:+15.40 (+1.29%)
Want to see IN:ZYDUSLIFE full AI Analyst Report?
Zydus Lifesciences Limited (ZYDUSLIFE) Financial Statements
9 Followers
Zydus Lifesciences Limited Financial Overview
Zydus Lifesciences Limited's market cap is currently ₹1.19T. The company's EPS TTM is ₹44.87; its P/E ratio is 28.97; and it has a dividend yield of 0.08%. Zydus Lifesciences Limited is estimated to report earnings on February 14, 2027, and the estimated EPS forecast is ₹8.50. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 271.48B | ₹ 232.41B | ₹ 195.47B | ₹ 172.37B | ₹ 151.10B |
| Gross Profit | ₹ 140.30B | ₹ 167.03B | ₹ 131.54B | ₹ 107.67B | ₹ 94.24B |
| Operating Income | ₹ 57.87B | ₹ 96.04B | ₹ 75.95B | ₹ 57.61B | ₹ 51.29B |
| EBITDA | ₹ 85.65B | ₹ 68.76B | ₹ 53.03B | ₹ 35.76B | ₹ 32.10B |
| Net Income | ₹ 50.40B | ₹ 45.26B | ₹ 38.59B | ₹ 19.60B | ₹ 44.87B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 71.92B | ₹ 78.08B | ₹ 13.58B | ₹ 11.92B | ₹ 35.05B |
| Total Assets | ₹ 524.07B | ₹ 372.02B | ₹ 292.81B | ₹ 257.56B | ₹ 277.95B |
| Total Debt | ₹ 124.96B | ₹ 32.13B | ₹ 8.04B | ₹ 11.95B | ₹ 42.21B |
| Net Debt | ₹ 110.79B | ₹ 2.56B | ₹ 3.91B | ₹ 7.07B | ₹ 35.63B |
| Total Liabilities | ₹ 228.24B | ₹ 108.43B | ₹ 71.79B | ₹ 60.68B | ₹ 87.42B |
| Stockholders' Equity | ₹ 271.11B | ₹ 239.53B | ₹ 198.29B | ₹ 175.16B | ₹ 170.00B |
| Cash Flow | |||||
| Free Cash Flow | ₹ -12.03B | ₹ 50.64B | ₹ 23.21B | ₹ 16.58B | ₹ 9.02B |
| Operating Cash Flow | ₹ 21.91B | ₹ 67.77B | ₹ 31.96B | ₹ 26.89B | ₹ 21.04B |
| Investing Cash Flow | ₹ -87.25B | ₹ -83.72B | ₹ -14.75B | ₹ 11.71B | ₹ -10.00B |
| Financing Cash Flow | ₹ 61.60B | ₹ 20.14B | ₹ -17.79B | ₹ -44.00B | ₹ -8.68B |
Currency in INR
